CNO
Get informed when a big investor buys or sells
+ FollowUndervalued by 168% based on the discounted cash flow analysis.
| Market cap | $4.29 Billion |
|---|---|
| Enterprise Value | $7.66 Billion |
| Dividend Yield | $0.68 (1.48%) |
| Earnings per Share | $2.35 |
| Beta | 0.83 |
| Outstanding Shares | 94,078,000 |
| P/E Ratio | 17.62 |
|---|---|
| PEG | 10.06 |
| Price to Sales | 0.98 |
| Price to Book Ratio | 1.78 |
| Enterprise Value to Revenue | 1.71 |
| Enterprise Value to EBIT | 30.07 |
| Enterprise Value to Net Income | 49 |
| Total Debt to Enterprise | 0.59 |
| Debt to Equity | 1.81 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7724▼ 14.85% |
|---|---|
| Total Calls | 12,300▲ 85.69% |
| Total Puts | 9,500▲ 55.74% |
Holdings and activity of institutional investors.
| Ownership % | 90.14%▲ 0.78% |
|---|---|
| Total Invested | $3.60B▼ 3.76% |
| Investors Holding | 361▼ 8.00% |
No data
Provides critical analysis and revenue estimates for all tax legislation. Directly influences corporate tax structures and investment incentives, significantly affecting CNO's financial performance.
Controls taxation and entitlement spending. Its decisions on corporate tax policy directly impact CNO's profitability and investment strategies, and social security/healthcare policy affects its client base.
Directly regulates the financial system, including federal oversight of financial institutions and consumer financial protection, which is highly relevant to CNO's insurance products and operations.